Filing Details

Accession Number:
0001209191-21-069092
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-10 17:04:17
Reporting Period:
2021-12-09
Accepted Time:
2021-12-10 17:04:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1044378 Biocept Inc BIOC Pharmaceutical Preparations (2834) CA
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1024004 F David Hale C/O Biocept, Inc.
9955 Mesa Rim Road
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-12-09 363 $4.06 3,114 No 4 S Indirect By LLC
Common Stock Disposition 2021-12-09 11 $4.07 101 No 4 S Indirect By trust
Common Stock Disposition 2021-12-09 71 $4.07 796 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By LLC
No 4 S Indirect By trust
No 4 S Direct
Footnotes
  1. The sales reported herein were made for tax planning purposes.